Jung Yeon Park

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death

Yujeong Moon, Man Kyu Shim, Jiwoong Choi et al. · Theranostics · 2022 · 126 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Self‐Assembled Peptide‐Derived Proteolysis‐Targeting Chimera (PROTAC) Nanoparticles for Tumor‐Targeted and Durable PD‐L1 Degradation in Cancer Immunotherapy

Yujeong Moon, Hanhee Cho, Jinseong Kim et al. · Angewandte Chemie International Edition · 2024 · 71 citations · Full text

Pharmacy, Oncology, Pharmaceutical Biotechnology +17

Light‐Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy

Jiwoong Choi, Byeongmin Park, Jung Yeon Park et al. · Advanced Materials · 2024 · 58 citations · Full text

Pharmacy, Biochemistry, Oncology +17

Photoswitchable Microgels for Dynamic Macrophage Modulation

Yuri Kim, Ramar Thangam, Jounghyun Yoo et al. · Advanced Materials · 2022 · 48 citations

Natural Sciences, Bioengineering, Materials Science +17

Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy

Nayeon Shim, Seong Ik Jeon, Suah Yang et al. · Biomaterials · 2022 · 44 citations

Pharmacy, Pharmaceutics, Pharmacology +17